by Mefloquine Awareness | Dec 7, 2017
A mosquito is pictured at the University of Arizona in this undated handout photo. The Irish government has agreed to pay a ‘substantial’ amount to a former army sergeant who was given the anti-malarial drug mefloquine in 2009. D. STOLTE, UNIVERSITY OF ARIZONA/THE...
by Mefloquine Awareness | Nov 1, 2017
Originally published October 31, 2017 Researchers have published two systematic reviews revealing the safety of mefloquine (Lariam) for preventing malaria in travellers. “Mefloquine is at least as effective as other options,” says Dr Tickell-Painter, from...
by Mefloquine Awareness | Oct 10, 2017
Antimalarials can have serious side effects & interactions with other meds. Malaria is serious, too, so you should discuss travel plans with a specialist. Originally published 10 October 2017. Overview Antimalarial drugs drugs are associated with severe and...
by Mefloquine Awareness | Oct 10, 2017
Defence Committee publish a six-monthly progress report from the UK Ministry of Defence. Six-monthly progress report ( PDF 2.87 MB) Inquiry: An acceptable risk? The use of Lariam for military personnel Defence Committee Report and Government Response On 24 May 2016,...
by Mefloquine Awareness | Sep 29, 2017
This U.S. Army photo, provided by the Tacoma, Wash., News Tribune, shows Staff Sgt. Robert Bales in March, 2012. (U.S. Army/Tacoma News-Tribune via AP) The sergeant, stationed in Washington state, was sentenced to life for the slayings of 16 Afghan civilians and...
by Mefloquine Awareness | Sep 26, 2017
Coverage from the XXIII World Congress of Neurology (WCN) Originally published 26 September 2017 KYOTO, Japan — The antimalarial drug mefloquine may prove to be an effective treatment for progressive multifocal leukoencephalopathy (PML) in patients not infected with...
